Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Allergy and Immunology

Vaccine/Immunotherapy

Evaluation of the BNT162b2 COVID-19 vaccine in children 5 to 11 years of age

New England Journal of Medicine | Nov 17, 2021 Vaccine/Immunotherapy

Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): A multicenter, randomized, controlled, phase 4 trial

The Lancet | Nov 17, 2021 Vaccine/Immunotherapy

Long-term first-in-man phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy

The Prostate | Nov 17, 2021 Vaccine/Immunotherapy

Antibody titers before and after a third dose of the BNT162b2 vaccine in older adults

JAMA | Nov 11, 2021 Vaccine/Immunotherapy

Durability of antibody levels after vaccination with mRNA SARS-CoV-2 vaccine in individuals with or without prior infection

JAMA | Nov 05, 2021 Vaccine/Immunotherapy

Waning immunity after the BNT162b2 vaccine in Israel

New England Journal of Medicine | Nov 01, 2021 Vaccine/Immunotherapy

Comparison of SARS-CoV-2 antibody response following vaccination with BNT162b2 and mRNA-1273

JAMA | Oct 24, 2021 Vaccine/Immunotherapy

Surveillance for adverse events after COVID-19 mRNA vaccination

JAMA | Oct 18, 2021 Vaccine/Immunotherapy

Humoral response after SARS-COV2 vaccination in patient undergoing maintenance hemodialysis: Loss of immunity, third dose and non-responders

Nephrology Dialysis Transplantation | Oct 17, 2021 Vaccine/Immunotherapy

Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US Military

JAMA Cardiology | Oct 17, 2021 Vaccine/Immunotherapy

« Prev 1 2 3 4 5 6 … 42 Next »

Evaluation of the BNT162b2 COVID-19 vaccine in children 5 to 11 years of age

Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): A multicenter, randomized, controlled, phase 4 trial

Long-term first-in-man phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy

Antibody titers before and after a third dose of the BNT162b2 vaccine in older adults

Durability of antibody levels after vaccination with mRNA SARS-CoV-2 vaccine in individuals with or without prior infection

Waning immunity after the BNT162b2 vaccine in Israel

Comparison of SARS-CoV-2 antibody response following vaccination with BNT162b2 and mRNA-1273

Surveillance for adverse events after COVID-19 mRNA vaccination

Humoral response after SARS-COV2 vaccination in patient undergoing maintenance hemodialysis: Loss of immunity, third dose and non-responders

Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US Military

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Anaesthetic Management in Obese Patients

Evaluation of the BNT162b2 COVID-19 vaccine in children 5 to 11 years of age

Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): A multicenter, randomized, controlled, phase 4 trial

Long-term first-in-man phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy

Antibody titers before and after a third dose of the BNT162b2 vaccine in older adults

Durability of antibody levels after vaccination with mRNA SARS-CoV-2 vaccine in individuals with or without prior infection

Waning immunity after the BNT162b2 vaccine in Israel

Comparison of SARS-CoV-2 antibody response following vaccination with BNT162b2 and mRNA-1273

Surveillance for adverse events after COVID-19 mRNA vaccination

Humoral response after SARS-COV2 vaccination in patient undergoing maintenance hemodialysis: Loss of immunity, third dose and non-responders

Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US Military

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Anaesthetic Management in Obese Patients

Select Specialty

Select Topic